Announcement

12
JUNE
2018


Category Label


Client Announcements

Verditek PLC : Successful First Stage CO2 Capture Test for WES

  •  
  •   12 June 2018

RNS Number : 0333R

Verditek PLC

12 June 2018

 

                                               

Verditek PLC
("Verditek" or the "Company")
 

Successful First Stage CO2 Capture Test for WES

 

Verditek plc, (AIM: VDTK), the clean technology company, is pleased to update shareholders that Westec Environment Solutions ("WES"), in which it is a major investor, is moving into large scale CO2 carbon capture testing, marking a significant milestone on its route to commercialisation.

 

SINTEF, Westec Environmental Solutions and CMC Research Institutes' Carbon Capture and Conversion Institute are working together on the INSPiRE project, to demonstrate the use of a proprietary precipitating solvent developed by SINTEF in the WES Regenerative Froth Contactor (RFC).  Completion of the first stage-gate included testing the solvent and RFC absorber at the SINTEF lab.

 

All required criteria were met, and the Steering Committee approved proceeding to the next stage, to include testing at the larger scale Tiller pilot plant in Trondheim, Norway. Particulars of the first stage of work will be presented at the GHGT-14 conference in Melbourne, Australia in October 2018.

 

The RFC technology developed at WES opens the door to significant size reductions and cost savings for post-combustion CO2 capture applications or H2S scrubbing of natural gas production. WES' RFC technology will be used in the oil and gas sector, fine chemicals, pharma and cement production.

 

Geoff Nesbitt, CEO of Verditek plc said: 

"Working with SINTEF has been a privilege for WES. As one of Europe's largest independent research organisations, and extremely well regarded by industry, SINTEF brings world-leading expertise and credibility to bear in any project. This is an important milestone in testing our technology and marks a significant step towards commercialisation. The results help validate the years of testing in our own pilot plant, as we move diligently towards delivering a new technology that can help make CO2 and H2S removal from any gas stream more economic to adopt. In this way we hope to help organisations comply with the global COP21 accord, and the IMO clean fuel initiatives.

 

Verditek remains dedicated to commercialising innovative clean technologies that can deliver significant competitive advantage compared to conventional industrial and residential solutions."

 

Enquiries:

Verditek plc

Geoffrey Nesbitt, CEO                                                                         +44 (0) 20 7129 1110

[email protected]  

Stockdale Securities Limited (NOMAD and Broker)

Antonio Bossi / David Coaten                                                             + 44 (0) 20 7601 6100

www.stockdalesecurities.com 

Strand Hanson Limited (Financial Adviser)

James Harris / Ritchie Balmer / Jack Botros                                      +44 (0) 20 7409 3494

www.strandhanson.co.uk 

Whiteoaks International

Mary Fitzgerald                                                                                   +44 (0) 7795 284440

Bekki Bushnell                                                                                    + 44 (0) 7841 698586

[email protected] 

 

About Verditek

Verditek plc (AIM: VDTK), the clean technology company is headquartered in London. Verditek is dedicated to commercialising proven technology that can deliver significant competitive advantage compared to conventional industrial solutions. From light-weight solar modules, cutting edge de-odourisation, and ground-breaking CO2 capture, Verditek is realising tomorrow's technologies today.

 

For further information, please visit www.verditek.com 

           

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 

END

 

 

NRAEAKKFFDNPEFF

;